Archive | Latest Research

Distinct Genomic Anomalies IDed in Melanoma Subtypes

NEW YORK (GenomeWeb) – A new study has delved more deeply than ever into the coding and non-coding alterations that occur in various forms of melanoma — including those do not seem to be attributable to mutations caused by sun exposure.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

A new unexpected key player in melanoma development identified

?Identification and functional validation of proteins involved in tumorigenesis are essential steps toward advancing cancer precision medicine.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

UI researchers document how melanoma tumors form

There’s a reason why melanoma, the most serious type of skin cancer, is so aggressive. You just need to watch the cells in action.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

BeiGene Presents Phase IB Data on RAF Dimer Inhibitor BGB-283 at the 2017 American Association for Cancer Research Annual Meeting

BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today presented data from the Phase IB dose expansion study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors in an oral presentation.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories